Valuation Cipla Limited LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. 2026-10-16			5-day change	1st Jan Change
14.00 ^USD	0.00%		+3.70%	-16.67%

10-06	Cipla Health Announces Appointment of Gaurav Kaul as Managing Director, Effective October 2026	CI
09-22	Cipla Limited and Cipla Usa Inc. Announces Management Changes, Effective October 1, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	821,377	726,839	1,208,588	1,164,745	988,887	1,070,482	-	-
Change	-	-11.51%	66.28%	-3.63%	-15.1%	8.25%	-	-
Enterprise Value (EV) ¹	810,334	716,397	1,154,239	1,084,736	901,599	964,380	939,033	922,715
Change	-	-11.59%	61.12%	-6.02%	-16.88%	6.96%	-2.63%	-1.74%
P/E	32.7x	26x	29.3x	22.1x	25.5x	25.8x	20.8x	18.4x
PBR	3.94x	3.11x	4.53x	3.73x	2.87x	2.85x	2.59x	2.33x
PEG	-	2.3x	0.6x	0.8x	-1x	3.79x	0.9x	1.4x
Capitalization / Revenue	3.77x	3.19x	4.69x	4.23x	3.51x	3.46x	3.09x	2.83x
EV / Revenue	3.72x	3.15x	4.48x	3.94x	3.2x	3.12x	2.71x	2.44x
EV / EBITDA	17.8x	14.3x	18.3x	15.2x	15.3x	16.2x	12.8x	11.3x
EV / EBIT	23.1x	18.6x	22x	18x	19.3x	20.7x	15.8x	13.6x
EV / FCF	29.1x	29.9x	38x	28.2x	38.5x	34x	26.1x	21.6x
FCF Yield	3.43%	3.35%	2.63%	3.54%	2.6%	2.94%	3.83%	4.64%
Dividend per Share ²	5	8.5	13	13	13	12.99	14.72	14.57
Rate of return	0.49%	0.94%	0.87%	0.9%	1.06%	0.98%	1.11%	1.1%
EPS ²	31.17	34.69	51.01	65.24	48	51.27	63.73	72.02
Distribution rate	16%	24.5%	25.5%	19.9%	27.1%	25.3%	23.1%	20.2%
Net sales ¹	217,633	227,531	257,741	275,476	281,626	309,296	346,822	378,322
EBITDA ¹	45,528	50,270	62,910	71,279	58,829	59,569	73,620	82,008
EBIT ¹	35,008	38,549	52,400	60,210	46,719	46,548	59,574	67,964
Net income ¹	25,168	28,019	41,216	52,725	38,792	41,182	51,590	58,286
Net Debt ¹	-11,043	-10,443	-54,350	-80,010	-87,289	-106,103	-131,449	-147,767
Reference price ²	1,018.05	900.50	1,496.95	1,442.20	1,224.20	1,325.10	1,325.10	1,325.10
Nbr of stocks (in thousands)	806,814	807,151	807,367	807,617	807,783	807,850	-	-
Announcement Date	5/10/22	5/12/23	5/10/24	5/13/25	5/13/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.8x	12.9x	27.02x	0.55%	1,116B
JOHNSON & JOHNSON	37.07x	6.25x	17.38x	2.11%	610B
ABBVIE INC.	36.17x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	112.15x	5.92x	25.35x	2.35%	358B
ROCHE HOLDING AG	20.49x	5x	12.4x	2.64%	366B
NOVARTIS AG	21.24x	5.55x	13.66x	2.88%	288B
ASTRAZENECA PLC	22x	4.43x	12.71x	1.99%	261B
AMGEN INC.	27.56x	7.08x	12.68x	2.32%	235B
GILEAD SCIENCES, INC.	-45.98x	7.04x	27.26x	2.1%	195B
Average	29.61x	6.94x	18.40x	2.15%	436.64B
Weighted average by Cap.	35.04x	8.17x	19.98x	1.84%